Skip to content

Bio-Techne TECH Cash Flow Statement

FY'25FY'24FY'23FY'22
$168.11M-41.1%$285.44M+8.5%$263.1M+88.5%
$109.9M-1.6%$111.71M+4.2%$107.24M+6.1%$101.07M+15.2%
$40.83M+7.3%$38.04M-7.9%$41.32M-2.1%$42.18M-13.9%
$287.56M-3.8%$298.98M+17.5%$254.39M-21.8%$325.27M-7.6%
$31.01M-50.7%$62.88M+64.4%$38.24M-14.8%$44.91M+1.4%
-$35.59M+82.5%-$203.03M+23.6%-$265.65M-174%-$96.85M+60.2%
$50.39M-0.1%$50.42M+0.3%$50.29M+0.2%$50.19M+1.1%
$80.04M
$77M-69.9%$256M-51.3%$525.66M+200%$175.5M-35.4%
-$253.91M-107%-$122.4M-$242.85M
$8M
$256.55M+8.7%$236.1M+9.2%$216.15M-22.9%$280.36M-8.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Bio-Techne generate?
Bio-Techne (TECH) generated $294.9M in operating cash flow over the trailing twelve months.
What is Bio-Techne's free cash flow?
After $25.3M of capital expenditures, Bio-Techne's free cash flow was $269.6M over the trailing twelve months, up 22.1% year over year.
Where does Bio-Techne's cash flow data come from?
Every line is extracted from Bio-Techne's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.